SCHEMBL882745

SCHEMBL882745

OCC1(CCCCCCCCCCCCC2(CO)CC2)C=C1

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.36
OPRL1 P41146 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL773239 0.83 OPRM1 (0.40) OPRM1OPRL1
SCHEMBL23971069 0.73 OPRM1 (0.35) OPRM1OPRL1
SCHEMBL3490658 0.73 GAA (0.43)
SCHEMBL798410 0.73 OPRM1 (0.38) OPRM1OPRL1
SCHEMBL7087554 0.73 DNM1 (0.38) OPRM1OPRL1
SCHEMBL6467762 0.71 OPRM1 (0.34) OPRM1OPRL1
SCHEMBL4359771 0.70 GAA (0.40) OPRM1OPRL1
SCHEMBL6530363 0.70 GRIN2D (0.37) OPRM1OPRL1
SCHEMBL1106724 0.70 OPRM1 (0.33) OPRM1OPRL1
SCHEMBL6463951 0.68 OPRM1 (0.35) OPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012040177-A1 METHODS AND COMPOSITIONS FOR TREATMENT OF DIABETES AND DYSLIPIDEMIA KAREUS THERAPEUTICS, SA (CH) 2012-03-29 WO disclosed